"","nctid","anticipated_enrollment","actual_enrollment","has_summary_result","start_date","stop_date","trial_days","source","reason_for_termination","reason_category","primary_reason_recoded"
"1","NCT00150878",172,198,FALSE,"2003-12-01","2009-12-01",2193,"Intovalue","Insurance coverage reached","non_scientific_reason","Administrative, logistical, or technical issues"
"2","NCT00480077",2300,335,TRUE,"2007-03-01","2012-01-01",1768,"Intovalue","Low enrollment rates","non_scientific_reason","Low accrual rate"
"3","NCT00618384",72,43,FALSE,"2008-01-01","2011-05-01",1217,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"4","NCT00640679",3000,782,FALSE,"2008-04-01","2012-08-01",1584,"Intovalue","Due to slow enrollment the study was stopped prematurely.","non_scientific_reason","Low accrual rate"
"5","NCT00672334",402,350,FALSE,"2008-05-01","2011-06-01",1127,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"6","NCT00690118",220,219,FALSE,"2008-05-01","2011-01-01",976,"Intovalue","The interim analysis showed no tendency in favour of the verum group. Therefore it was decided to stop the study prematurely.","scientific_reason","Evidence of futility"
"7","NCT00716833",120,87,FALSE,"2006-02-01","2010-12-01",1765,"Intovalue","poor recruitment","non_scientific_reason","Low accrual rate"
"8","NCT00798525",240,70,FALSE,"2009-01-01","2012-03-01",1156,"Intovalue","Supply of Lepirudin ended on 01. April 2012, thus trial terminated on 31. March 2012","non_scientific_reason","Lack of investigational product"
"9","NCT00803309",150,99,FALSE,"2008-11-01","2013-08-01",1735,"Intovalue","At the end of the planned recruitment period the expected number of subjects could not be included in the trial.","non_scientific_reason","Low accrual rate"
"10","NCT00986258",180,136,TRUE,"2009-10-01","2010-12-01",427,"Intovalue","This clinical trial was terminated early, due to slow recruitment and study drug shortages.","non_scientific_reason","Low accrual rate"
"11","NCT00996554",942,252,FALSE,"2004-01-01","2012-01-01",2923,"Intovalue","Feasibility reasons; recruitment was too slow.","non_scientific_reason","Low accrual rate"
"12","NCT00999856",65,28,FALSE,"2008-08-01","2012-03-01",1309,"Intovalue","Two cohorts successfully completed; further cohorts not needed; no safety issue!","scientific_reason","Evidence of benefit"
"13","NCT01021423",382,9,TRUE,"2010-04-01","2011-03-01",335,"Intovalue","Terminated by sponsor due to new unpublished data that rendered the current design of the study no longer clinically relevant. There were no safety concerns.","scientific_reason","External evidence"
"14","NCT01030666",61,61,TRUE,"2007-04-01","2011-01-01",1372,"Intovalue","shelf life of investigational drug ran out before 90 patients could be included","non_scientific_reason","Lack of investigational product"
"15","NCT01143272",1520,477,TRUE,"2010-06-01","2012-11-01",885,"Intovalue","Masked independent interim analysis: completion of the trial was unlikely.","scientific_reason","Evidence of futility"
"16","NCT01178255",228,44,FALSE,"2010-08-01","2011-11-01",458,"Intovalue","recruitment difficulties","non_scientific_reason","Low accrual rate"
"17","NCT01239992",20,12,TRUE,"2011-06-01","2013-01-01",581,"Intovalue","negative endpoint study resulting in withdrawal of study drug","scientific_reason","External evidence"
"18","NCT01297712",1069,1069,FALSE,"2009-09-01","2010-11-01",427,"Intovalue","enrollment terminated, analysis ongoing","other","Other"
"19","NCT01339026",140,44,FALSE,"2012-02-01","2013-09-01",579,"Intovalue","Change in guidelines favouring newer antiplatelet drugs in ACS","scientific_reason","External evidence"
"20","NCT01564095",86,25,FALSE,"2011-10-01","2013-07-01",640,"Intovalue","Missing evidence of the effectiveness of the study medication","scientific_reason","Evidence of futility"
"21","NCT01601496",150,117,TRUE,"2009-10-26","2013-07-24",1368,"Intovalue","Slow Enrollment","non_scientific_reason","Low accrual rate"
"22","NCT00626548",1500,2577,TRUE,"2008-01-01","2011-03-01",1156,"Intovalue","early efficacy review by the Independent Data Monitoring Committee indicated it was unlikely to meet its primary efficacy endpoints","scientific_reason","Evidence of futility"
"23","NCT00746720",52,23,FALSE,"2006-05-01","2009-07-01",1158,"Intovalue","Patient recruitment difficulties","non_scientific_reason","Low accrual rate"
"24","NCT00368121",33,13,FALSE,"2006-08-01","2012-06-01",2132,"Intovalue","Lack of recruitable patients","non_scientific_reason","Low accrual rate"
"25","NCT00502554",20,12,FALSE,"2007-08-01","2010-04-01",975,"Intovalue","insufficient patient recruitment and ECP capacity","non_scientific_reason","Low accrual rate"
"26","NCT00663104",126,126,FALSE,"2008-04-01","2009-06-01",427,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"27","NCT00667667",108,108,FALSE,"2008-04-01","2009-06-01",427,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"28","NCT00708942",150,83,TRUE,"2009-01-01","2012-01-01",1096,"Intovalue","Slow recruitment, study stopped with only 13 of 70 patients included in second part of the study","non_scientific_reason","Low accrual rate"
"29","NCT00720850",50,10,FALSE,"2008-04-01","2011-01-01",1006,"Intovalue","Low recruitment, scientific rationale not applicable anymore to all patients and possible induction of GvHD by the study drug","scientific_reason","Evidence of harm"
"30","NCT00823290",18,2,FALSE,"2009-01-01","2010-12-01",700,"Intovalue","Investigator left site","non_scientific_reason","Principal investigator departure"
"31","NCT00933374",30,28,FALSE,"2009-07-01","2012-11-01",1220,"Intovalue","delayed recruitment","non_scientific_reason","Low accrual rate"
"32","NCT01079091",160,14,FALSE,"2010-09-01","2013-07-01",1035,"Intovalue","The foundations of our pilotstudy planning has changed.","non_scientific_reason","Administrative, logistical, or technical issues"
"33","NCT01079104",184,7,FALSE,"2010-09-01","2013-08-01",1066,"Intovalue","The foundations of our pilotstudy planning has changed.","non_scientific_reason","Administrative, logistical, or technical issues"
"34","NCT01187888",112,44,FALSE,"2010-01-01","2012-06-01",883,"Intovalue","IMP used off label by phys. in pat. with PSP. Thus no more eligible patients were available for the study(pre-treatm.with Rasagiline=exclusion criterion","non_scientific_reason","Administrative, logistical, or technical issues"
"35","NCT01215266",98,98,FALSE,"2006-10-01","2011-06-01",1705,"Intovalue","Slow recruitment","non_scientific_reason","Low accrual rate"
"36","NCT01245985",50,8,FALSE,"2010-11-01","2012-11-01",732,"Intovalue","slow recruitment (only 8 patients recruited and treated until 12&#x2F;2012)","non_scientific_reason","Low accrual rate"
"37","NCT00125606",172,30,FALSE,"2004-10-01","2011-07-01",2465,"Intovalue","insufficient patient recruitement","non_scientific_reason","Low accrual rate"
"38","NCT00331721",72,24,FALSE,"2006-05-01","2009-05-01",1097,"Intovalue","Scientific data called into question the viability of the substance class","scientific_reason","External evidence"
"39","NCT00368264",44,1,FALSE,"2006-09-01","2009-06-01",1005,"Intovalue","Failure to recruit patients with membranous lupus nephritis not previously treated with azathioprine .","non_scientific_reason","Low accrual rate"
"40","NCT00405873",73,73,FALSE,"2007-03-01","2010-03-01",1097,"Intovalue","Lack of efficacy","scientific_reason","Evidence of futility"
"41","NCT00457951",66,158,TRUE,"2007-04-01","2009-08-01",854,"Intovalue","Interim analysis: safety without efficacy ODSH in patients with acute COPD.","scientific_reason","Evidence of futility"
"42","NCT00511160",120,120,FALSE,"2007-08-01","2010-08-01",1097,"Intovalue","Study suspended due to logistical&#x2F;personnel difficulties","non_scientific_reason","Administrative, logistical, or technical issues"
"43","NCT00586794",80,24,FALSE,"2007-12-01","2012-03-01",1553,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"44","NCT00623415",80,30,FALSE,"2007-12-01","2012-11-01",1798,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"45","NCT00628797",60,9,FALSE,"2008-02-01","2010-07-01",882,"Intovalue","lack of recruitement","non_scientific_reason","Low accrual rate"
"46","NCT00647192",220,38,FALSE,"2008-03-01","2012-02-01",1433,"Intovalue","Inclusion rate too low. Recruitment of further study centers too costly.","non_scientific_reason","Low accrual rate"
"47","NCT00663455",50,50,FALSE,"2008-12-01","2012-12-01",1462,"Intovalue","Recruitment goals were not achieved. Extension of the trial concept had to be abjected due to methodological reasons.","non_scientific_reason","Low accrual rate"
"48","NCT00682747",100,13,FALSE,"2008-05-01","2011-03-01",1035,"Intovalue","poor recruitment","non_scientific_reason","Low accrual rate"
"49","NCT00691912",6,26,FALSE,"2006-12-01","2013-12-01",2558,"Intovalue","Study was stopped due because recrutation.was much slower as anticipated.","non_scientific_reason","Low accrual rate"
"50","NCT00704002",80,9,FALSE,"2006-12-01","2010-02-01",1159,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"51","NCT00776191",25,5,FALSE,"2008-09-01","2012-05-01",1339,"Intovalue","al study sites stoped on 15&#x2F;05&#x2F;2012 because of insufficient recrutement.","non_scientific_reason","Low accrual rate"
"52","NCT00806468",20,1,FALSE,"2009-02-01","2010-12-01",669,"Intovalue","lack of recruitment","non_scientific_reason","Low accrual rate"
"53","NCT00823225",130,5,FALSE,"2008-06-01","2011-05-01",1065,"Intovalue","Insufficient recruitment of study patients","non_scientific_reason","Low accrual rate"
"54","NCT00852059",106,32,FALSE,"2009-03-01","2013-12-01",1737,"Intovalue","Diffculties to recruit anticipated study size, now analysis","non_scientific_reason","Low accrual rate"
"55","NCT00866684",280,44,FALSE,"2007-01-01","2011-01-01",1462,"Intovalue","Insufficient patient recruitment","non_scientific_reason","Low accrual rate"
"56","NCT00881257",50,78,FALSE,"2007-08-01","2009-11-01",824,"Intovalue","Data was inconclusive","scientific_reason","Evidence of futility"
"57","NCT00887276",290,290,FALSE,"2008-11-01","2011-01-01",792,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"58","NCT00930241",48,25,FALSE,"2009-07-01","2012-07-01",1097,"Intovalue","logistic reasons (insufficient funding, technical problems with MEMS)","non_scientific_reason","Lack of funding"
"59","NCT00932724",250,77,FALSE,"2009-07-01","2012-08-01",1128,"Intovalue","The sponsor declared the early termination of the study due to poor recruitment of patients.","non_scientific_reason","Low accrual rate"
"60","NCT00939939",40,3,FALSE,"2010-03-01","2011-05-01",427,"Intovalue","Recruitment failure","non_scientific_reason","Low accrual rate"
"61","NCT00967343",70,40,TRUE,"2009-08-01","2012-02-01",915,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"62","NCT01058369",45,2,TRUE,"2010-04-01","2013-01-01",1007,"Intovalue","Insufficient patient recruitment (only 2 patients)","non_scientific_reason","Low accrual rate"
"63","NCT01058759",216,14,FALSE,"2009-11-01","2011-02-01",458,"Intovalue","The external funding (pharmaceutical company) was stopped and could not be substituded by internal funding.","non_scientific_reason","Lack of funding"
"64","NCT01069601",120,13,FALSE,"2010-02-01","2011-04-01",425,"Intovalue","End of H1N1 Swine Flu Pandemic","other","Other"
"65","NCT01069965",300,196,FALSE,"2010-10-01","2013-08-01",1036,"Intovalue","Funding support withdrawn.","non_scientific_reason","Lack of funding"
"66","NCT01071135",5,5,FALSE,"2009-09-01","2010-08-01",335,"Intovalue","Planned number of 30 subjects could not be recruited during recruitment phase.","non_scientific_reason","Low accrual rate"
"67","NCT01088256",62,9,FALSE,"2011-02-01","2012-08-01",548,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"68","NCT01088308",30,18,FALSE,"2010-03-01","2012-05-01",793,"Intovalue","No enrollements for more than 6 months in Phase II","non_scientific_reason","Low accrual rate"
"69","NCT01098565",25,6,FALSE,"2010-04-01","2011-11-01",580,"Intovalue","The goal of collecting proof-of-concept information was met through additional modeling studies, new published evidence and information collected from the study","scientific_reason","Evidence of benefit"
"70","NCT01109966",228,34,FALSE,"2010-06-01","2012-10-01",854,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"71","NCT01199133",471,471,FALSE,"2009-10-01","2011-01-01",458,"Intovalue","Following the DSMB recommendation. Study population being insufficiently symptomatic to enable differentiation between treatment and placebo. No safety concerns","scientific_reason","Evidence of futility"
"72","NCT01199783",120,1,FALSE,"2011-07-01","2013-10-01",824,"Intovalue","Patient number to be enrolled not reachable in prospected time frame, decision to stop the study prematurely was made.","non_scientific_reason","Low accrual rate"
"73","NCT01231854",78,15,FALSE,"2010-11-01","2012-03-01",487,"Intovalue","delayed start of the trial, both treatment options already have market authorizations, study medication expired","non_scientific_reason","Administrative, logistical, or technical issues"
"74","NCT01298830",20,11,FALSE,"2008-10-01","2011-06-01",974,"Intovalue","Need for improvement of study medication. Safety data collected sufficient. No further gain in knowledge expected.","scientific_reason","Evidence of harm"
"75","NCT01320280",29,29,FALSE,"2011-05-01","2012-11-01",551,"Intovalue","unexpectedly slow recruitment","non_scientific_reason","Low accrual rate"
"76","NCT01341340",90,2,FALSE,"2011-08-01","2012-11-01",459,"Intovalue","Discontinued due to poor enrollment. Insufficient number of patients enrolled to permit a statistically rigorous assessment of safety and efficacy.","non_scientific_reason","Low accrual rate"
"77","NCT01357460",25,18,FALSE,"2011-05-01","2014-09-24",1243,"Intovalue","difficult patient recruitment","non_scientific_reason","Low accrual rate"
"78","NCT01363921",12,10,FALSE,"2011-04-01","2013-09-01",885,"Intovalue","insufficient patient recruiting","non_scientific_reason","Low accrual rate"
"79","NCT01367691",20,1,FALSE,"2011-06-01","2013-12-01",915,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"80","NCT01374789",124,2,FALSE,"2010-07-01","2014-04-01",1371,"Intovalue","The study was terminated due to insufficient recruitment.","non_scientific_reason","Low accrual rate"
"81","NCT01409850",40,36,FALSE,"2010-07-01","2012-12-01",885,"Intovalue","Very slow enrollment of participants","non_scientific_reason","Low accrual rate"
"82","NCT01410903",7,1,FALSE,"2011-04-01","2012-07-01",458,"Intovalue","inadequately recruitment rate, funding is not secured","non_scientific_reason","Low accrual rate"
"83","NCT01434914",70,9,FALSE,"2011-10-01","2013-07-01",640,"Intovalue","early termination due to poor recruitment","non_scientific_reason","Low accrual rate"
"84","NCT01447758",33,58,FALSE,"2011-09-01","2013-03-01",548,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"85","NCT01458015",52,5,FALSE,"2011-10-01","2013-11-01",763,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"86","NCT01531764",40,2,FALSE,"2012-07-01","2013-09-01",428,"Intovalue","The recruitment was discontinued because of failure to meet expected enrolment goals","non_scientific_reason","Low accrual rate"
"87","NCT01551407",34,38,FALSE,"2011-12-01","2012-06-01",184,"Intovalue","slow inclusion rate","non_scientific_reason","Low accrual rate"
"88","NCT01571895",12,4,FALSE,"2011-07-01","2012-06-01",337,"Intovalue","Lack of efficacy observed at 1&#x2F;3 of the enrollment at investigated dosage. No results available.","scientific_reason","Evidence of futility"
"89","NCT01638585",211,34,FALSE,"2011-06-01","2012-11-01",520,"Intovalue","recruition number was not reached","non_scientific_reason","Low accrual rate"
"90","NCT01701843",30,7,FALSE,"2012-10-01","2013-02-01",124,"Intovalue","prematurely terminated because of low recruitment","non_scientific_reason","Low accrual rate"
"91","NCT01740544",40,16,FALSE,"2012-10-01","2012-12-01",62,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"92","NCT02188212",53,53,FALSE,"2010-03-01","2013-11-01",1342,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"93","NCT00839059",40,14,FALSE,"2009-01-01","2011-05-01",851,"Intovalue","Results of an interim analysis and a hardly ongoing enrolment in the last 10 months in all six participating centres","scientific_reason","Evidence of futility"
"94","NCT01476553",64,30,FALSE,"2011-02-01","2013-12-01",1035,"Intovalue","Prematurely halted after interim data analysis","scientific_reason","Internal evidence (unspecified)"
"95","NCT01589211",800,347,FALSE,"2011-12-16","2013-04-11",483,"Intovalue","Necessary number of participants not achieved and high drop out rate","non_scientific_reason","Low accrual rate"
"96","NCT01352702",70,46,FALSE,"2011-05-01","2014-05-01",1097,"Intovalue","Slow recruitment; Study was terminated for futility reasons","scientific_reason","Evidence of futility"
"97","NCT02207582",60,44,FALSE,"2014-07-01","2017-01-01",916,"Intovalue","no efficacy","scientific_reason","Evidence of futility"
"98","NCT02372318",25,23,FALSE,"2015-04-01","2016-05-01",397,"Intovalue","Anticipated nr of 25 probands was not reached in terms of full data sets (missing data, low fMRI data quality), but time frame for recruitment ended.","non_scientific_reason","Low accrual rate"
"99","NCT02129400",96,36,FALSE,"2014-05-01","2015-01-01",246,"Intovalue","The analysis of the blood samples was much expensive than calculated. The recruitment had to be stopped after 36 study participants.","non_scientific_reason","Lack of funding"
"100","NCT02135926",600,4,FALSE,"2014-03-01","2018-02-01",1434,"Intovalue","Results from other RCT made randomization unethical.","scientific_reason","External evidence"
"101","NCT01817738",200,197,FALSE,"2012-08-01","2016-08-01",1462,"Intovalue","Follow up period after primary analysis was prematurely stopped because more mature data will not impact the study outcome","scientific_reason","Internal evidence (unspecified)"
"102","NCT02034279",512,136,FALSE,"2014-05-01","2016-12-31",976,"Intovalue","Low recruitment rate and expiration of the study drug","non_scientific_reason","Low accrual rate"
"103","NCT02340299",68,6,TRUE,"2015-01-01","2017-12-31",1096,"Intovalue","Slow recruitment","non_scientific_reason","Low accrual rate"
"104","NCT01647880",88,15,FALSE,"2013-07-01","2016-04-01",1006,"Intovalue","delayed recruitment","non_scientific_reason","Low accrual rate"
"105","NCT01440062",80,55,FALSE,"2011-12-01","2018-12-01",2558,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"106","NCT01402739",116,100,FALSE,"2011-08-01","2015-06-01",1401,"Intovalue","Study terminated prematurely due to futility","scientific_reason","Evidence of futility"
"107","NCT01111448",40,20,FALSE,"2010-04-01","2013-06-01",1158,"Intovalue","Unfavourable Risk-Benefit-Ratio","scientific_reason","Evidence of harm"
"108","NCT02078986",50,50,FALSE,"2014-02-01","2015-02-01",366,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"109","NCT01569412",24,14,FALSE,"2012-03-01","2016-05-01",1523,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"110","NCT01067703",2070,1400,FALSE,"2010-12-01","2014-05-01",1248,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"111","NCT01853384",440,252,TRUE,"2013-11-01","2015-12-01",761,"Intovalue","based on outcome of trial NCT01656889.","scientific_reason","External evidence"
"112","NCT01148264",86,23,FALSE,"2010-07-01","2013-10-01",1189,"Intovalue","poor enrolment","non_scientific_reason","Low accrual rate"
"113","NCT01203228",160,129,FALSE,"2004-05-01","2015-01-01",3898,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"114","NCT02384850",27,10,TRUE,"2015-03-01","2017-03-09",740,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"115","NCT01900327",410,32,FALSE,"2014-02-01","2016-11-22",1026,"Intovalue","Recruitment failure","non_scientific_reason","Low accrual rate"
"116","NCT01405417",58,70,FALSE,"2011-04-01","2012-07-01",458,"Intovalue","not enough data collected","non_scientific_reason","Administrative, logistical, or technical issues"
"117","NCT01931592",47,29,FALSE,"2014-01-01","2016-10-01",1005,"Intovalue","One of the study drugs was no longer available on a worldwide level.","non_scientific_reason","Lack of investigational product"
"118","NCT01852526",40,5,FALSE,"2013-03-01","2017-02-01",1434,"Intovalue","device failure","non_scientific_reason","Administrative, logistical, or technical issues"
"119","NCT02699034",35,5,FALSE,"2016-03-01","2017-03-01",366,"Intovalue","Recommendation by BfArM after interim analysis","scientific_reason","Internal evidence (unspecified)"
"120","NCT02380937",30,8,FALSE,"2015-01-01","2015-08-01",213,"Intovalue","The study was terminated prematurely on 05May 2015 because of the unavailability of study devices.","non_scientific_reason","Lack of investigational product"
"121","NCT00923793",150,53,FALSE,"2009-06-01","2014-04-01",1766,"Intovalue","Recruitment was stopped, due to slow recruitment rate","non_scientific_reason","Low accrual rate"
"122","NCT01534455",80,43,FALSE,"2012-02-01","2015-03-01",1125,"Intovalue","very slow patient recruitment and concerns about the actuality of the study design","non_scientific_reason","Low accrual rate"
"123","NCT02424552",160,54,FALSE,"2015-06-26","2017-02-09",595,"Intovalue","recruitment problems","non_scientific_reason","Low accrual rate"
"124","NCT01679405",19,9,TRUE,"2012-08-01","2016-04-01",1340,"Intovalue","No sufficient clinical or molecular signals for efficacy were observed.","scientific_reason","Evidence of futility"
"125","NCT01841632",12,3,TRUE,"2013-04-01","2016-12-01",1341,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"126","NCT01540344",60,26,FALSE,"2010-10-01","2015-09-01",1797,"Intovalue","Slow recruitment.","non_scientific_reason","Low accrual rate"
"127","NCT00950274",142,81,FALSE,"2009-07-01","2016-03-01",2436,"Intovalue","Recruitment stopped due to slow recruitment","non_scientific_reason","Low accrual rate"
"128","NCT02052193",42,8,FALSE,"2014-01-01","2017-01-01",1097,"Intovalue","Second cohort not opened because Simon-Two_Step model failed","scientific_reason","Evidence of futility"
"129","NCT01055522",129,102,FALSE,"2008-06-01","2013-02-01",1707,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"130","NCT02820519",12,4,FALSE,"2016-06-01","2017-07-21",416,"Intovalue","Intolerable high amount of adverse events","scientific_reason","Evidence of harm"
"131","NCT01532453",300,244,TRUE,"2010-11-01","2014-01-01",1158,"Intovalue","For futility reasons and potential &quot;loss of chance&quot; for MD 3511356 group","scientific_reason","Evidence of futility"
"132","NCT03854942",120,43,FALSE,"2011-08-30","2017-12-13",2298,"Intovalue","Recruitment rate could not be met in the study period, review group was dissolved before regular end of study. Recruitment was therefore terminated.","non_scientific_reason","Low accrual rate"
"133","NCT02585752",20,20,FALSE,"2015-10-01","2017-09-30",731,"Intovalue","Low recruitment","non_scientific_reason","Low accrual rate"
"134","NCT02539680",30,18,FALSE,"2015-09-01","2017-10-01",762,"Intovalue","insufficiant recruitment","non_scientific_reason","Low accrual rate"
"135","NCT02077309",60,4,FALSE,"2014-08-01","2015-09-01",397,"Intovalue","bad recruitment of suitable participants, just 4 patients in one year","non_scientific_reason","Low accrual rate"
"136","NCT01941550",35,11,FALSE,"2013-07-01","2016-01-01",915,"Intovalue","Investigator left the site. Site closed.","non_scientific_reason","Principal investigator departure"
"137","NCT01888796",60,8,FALSE,"2013-09-01","2014-12-01",457,"Intovalue","bad recruitment of suitable participants, just 8 patients in one year","non_scientific_reason","Low accrual rate"
"138","NCT01341106",100,7,FALSE,"2011-04-01","2015-01-01",1372,"Intovalue","insufficient patient numbers have been recruited","non_scientific_reason","Low accrual rate"
"139","NCT01266187",430,16,FALSE,"2011-07-01","2015-09-01",1524,"Intovalue","Recruitment difficulities","non_scientific_reason","Low accrual rate"
"140","NCT01262729",100,5,FALSE,"2011-09-01","2014-11-01",1158,"Intovalue","Feasibility and Recruitment problems","non_scientific_reason","Low accrual rate"
"141","NCT01242956",400,100,FALSE,"2011-09-01","2014-11-01",1158,"Intovalue","Problem to recruit sufficient patient number","non_scientific_reason","Low accrual rate"
"142","NCT02475252",150,15,FALSE,"2015-04-01","2016-01-01",276,"Intovalue","Recruitment too slow; study completion not possible within frame","non_scientific_reason","Low accrual rate"
"143","NCT01402414",50,10,FALSE,"2011-04-01","2014-02-01",1038,"Intovalue","Difficulties with the Recruitement","non_scientific_reason","Low accrual rate"
"144","NCT01563614",9,1,FALSE,"2012-03-01","2015-11-01",1341,"Intovalue","No patients can be recruited for this trial anymore due to other therapeutical approaches that became available.","scientific_reason","External evidence"
"145","NCT02726048",40,4,FALSE,"2016-04-01","2017-07-01",457,"Intovalue","Fisher &amp; Paykel Healthcare placed an administrative hold on the Simplus and Eson Non-Invasive Ventilation Evaluation study being conducted at Charite, Berlin","non_scientific_reason","Administrative, logistical, or technical issues"
"146","NCT02019498",220,50,FALSE,"2014-04-01","2016-02-01",672,"Intovalue","Recruitment problems","non_scientific_reason","Low accrual rate"
"147","NCT01523938",120,72,FALSE,"2012-03-01","2014-04-01",762,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"148","NCT01370044",288,96,FALSE,"2012-08-01","2015-06-01",1035,"Intovalue","results of interim analysis (not safety relevant)","scientific_reason","Evidence of futility"
"149","NCT01259830",90,81,FALSE,"2011-03-01","2014-04-01",1128,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"150","NCT02157363",73,47,FALSE,"2014-06-01","2017-06-01",1097,"Intovalue","poor recruitment due to change of surgical technique","non_scientific_reason","Low accrual rate"
"151","NCT01146821",21,7,FALSE,"2013-10-01","2017-04-01",1279,"Intovalue","Low enrollment&#x2F; expiration of the grant","non_scientific_reason","Low accrual rate"
"152","NCT02595840",4,4,FALSE,"2015-11-25","2017-11-20",727,"Intovalue","Futility","scientific_reason","Evidence of futility"
"153","NCT02541357",108,4,FALSE,"2015-09-01","2017-03-01",548,"Intovalue","Recruitment insufficient","non_scientific_reason","Low accrual rate"
"154","NCT02488694",210,4,FALSE,"2015-11-01","2017-12-01",762,"Intovalue","unsufficient recruitment","non_scientific_reason","Low accrual rate"
"155","NCT02185703",100,51,FALSE,"2014-07-01","2015-07-01",366,"Intovalue","Too slow recruitment rate","non_scientific_reason","Low accrual rate"
"156","NCT02150473",30,21,FALSE,"2014-10-01","2017-09-14",1080,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"157","NCT01755871",250,8,FALSE,"2013-01-01","2016-01-01",1096,"Intovalue","lack of recruitment","non_scientific_reason","Low accrual rate"
"158","NCT00977132",80,23,FALSE,"2009-10-01","2012-08-01",1036,"Intovalue","delayed recruitment","non_scientific_reason","Low accrual rate"
"159","NCT01176214",100,7,FALSE,"2010-07-01","2014-04-01",1371,"Intovalue","slow recruitment of patients","non_scientific_reason","Low accrual rate"
"160","NCT02081053",40,30,FALSE,"2014-01-01","2016-11-01",1036,"Intovalue","Difficulty Enrolling","non_scientific_reason","Low accrual rate"
"161","NCT00945126",45,68,FALSE,"2006-12-01","2017-08-01",3897,"Intovalue","Poor accrural","non_scientific_reason","Low accrual rate"
"162","NCT00711542",100,31,FALSE,"2008-09-01","2014-12-01",2283,"Intovalue","Slow recruitment","non_scientific_reason","Low accrual rate"
"163","NCT01690572",30,14,FALSE,"2012-10-01","2016-12-01",1523,"Intovalue","recruitment was not sufficient.","non_scientific_reason","Low accrual rate"
"164","NCT01517776",33,28,FALSE,"2012-01-01","2014-03-01",791,"Intovalue","due to an altered benefit&#x2F;risk assessment.","scientific_reason","Evidence of harm"
"165","NCT01060423",80,8,FALSE,"2010-02-01","2011-12-01",669,"Intovalue","Terminated due to poor subject enrolment","non_scientific_reason","Low accrual rate"
"166","NCT01045512",400,96,FALSE,"2009-10-01","2014-09-01",1797,"Intovalue","unsufficient recruitment","non_scientific_reason","Low accrual rate"
"167","NCT02818959",7,7,FALSE,"2013-12-01","2014-03-01",91,"Intovalue","Due to inability to recruit sufficient sample size in reasonable time frame.","non_scientific_reason","Low accrual rate"
"168","NCT02606799",24,5,FALSE,"2016-05-01","2017-04-01",336,"Intovalue","No further recruitment possible due to changed conditions","non_scientific_reason","Administrative, logistical, or technical issues"
"169","NCT02417103",30,2,FALSE,"2011-12-01","2016-09-01",1737,"Intovalue","Recruiting failure","non_scientific_reason","Low accrual rate"
"170","NCT02071511",50,50,FALSE,"2014-01-01","2016-01-01",731,"Intovalue","The Sponsor appreciate the devastating impact that the results of the SYMPLICITY HTN 3 trial had on research progress for renal denervation. Based on the lack of recent progress, it is no longer practical to maintain the agreement.","scientific_reason","External evidence"
"171","NCT01887041",128,24,FALSE,"2010-01-01","2015-12-01",2161,"Intovalue","Recruiting problems","non_scientific_reason","Low accrual rate"
"172","NCT01759238",72,1,FALSE,"2013-05-01","2014-10-01",519,"Intovalue","unexpectedly slow recruitment","non_scientific_reason","Low accrual rate"
"173","NCT01021202",40,23,FALSE,"2009-10-01","2014-04-01",1644,"Intovalue","unexpectedly slow recruitment","non_scientific_reason","Low accrual rate"
"174","NCT00858793",10,5,FALSE,"2008-11-28","2016-08-31",2834,"Intovalue","A leukaemia case was reported in patient treated with a similar vector. For safety risk we stopped recruitment","scientific_reason","External evidence"
"175","NCT02728453",60,7,FALSE,"2016-04-27","2017-09-25",517,"Intovalue","Insufficient recruitment.","non_scientific_reason","Low accrual rate"
"176","NCT02374567",2000,407,FALSE,"2015-01-01","2017-06-28",910,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"177","NCT01336530",810,40,FALSE,"2011-04-01","2017-01-01",2103,"Intovalue","The study stopped prematurely due to and administrative reasons, not based on grounds of safety.","non_scientific_reason","Administrative, logistical, or technical issues"
"178","NCT01117662",118,13,FALSE,"2012-05-01","2016-05-01",1462,"Intovalue","The planned recruitment number of 180 Patient could not been achieved.","non_scientific_reason","Low accrual rate"
"179","NCT02772146",16,2,FALSE,"2016-05-11","2017-01-23",258,"Intovalue","After 2 patients it was concluded that a large change in exclusion criteria and study design was needed to obtain the ojective for the study","non_scientific_reason","Administrative, logistical, or technical issues"
"180","NCT02130128",10,6,FALSE,"2014-04-01","2014-12-01",245,"Intovalue","Sufficient clinical evidence was gathered","scientific_reason","Internal evidence (unspecified)"
"181","NCT01666600",90,63,FALSE,"2012-08-01","2017-03-01",1674,"Intovalue","Interim Analysis for Feasibility","scientific_reason","Evidence of futility"
"182","NCT01617980",15,4,FALSE,"2012-04-01","2014-03-01",700,"Intovalue","Slow accrual","non_scientific_reason","Low accrual rate"
"183","NCT01362582",120,32,FALSE,"2010-03-01","2014-08-01",1615,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"184","NCT00753441",100,24,FALSE,"2009-02-01","2017-08-16",3119,"Intovalue","Low patient accrual","non_scientific_reason","Low accrual rate"
"185","NCT01522612",150,5,FALSE,"2013-04-01","2015-03-01",700,"Intovalue","poor accrual","non_scientific_reason","Low accrual rate"
"186","NCT02641782",36,3,FALSE,"2015-11-01","2016-12-23",419,"Intovalue","Antibody supply was discontinued by United Therapeutics Corporation.","non_scientific_reason","Lack of investigational product"
"187","NCT02891863",9,9,TRUE,"2015-09-01","2016-03-01",183,"Intovalue","Futility","scientific_reason","Evidence of futility"
"188","NCT02523859",530,25,FALSE,"2015-07-01","2016-06-01",337,"Intovalue","Poor recruitment","non_scientific_reason","Low accrual rate"
"189","NCT00595647",240,162,FALSE,"2008-02-01","2014-03-01",2221,"Intovalue","insufficient enrollment","non_scientific_reason","Low accrual rate"
"190","NCT02039167",300,14,FALSE,"2014-01-01","2017-03-21",1176,"Intovalue","The recruitment rate was very poor. The study was stopped by amendment on 2015-08-28.","non_scientific_reason","Low accrual rate"
"191","NCT02594332",90,29,FALSE,"2015-11-17","2017-05-22",553,"Intovalue","recruitment problems","non_scientific_reason","Low accrual rate"
"192","NCT01340690",438,284,FALSE,"2011-03-08","2016-03-31",1851,"Intovalue","The sample size of the planned interims analysis was achieved","other","Other"
"193","NCT00659867",200,182,FALSE,"2008-12-01","2014-03-01",1917,"Intovalue","Recruitment problems","non_scientific_reason","Low accrual rate"
"194","NCT02312479",15,6,FALSE,"2014-12-01","2015-11-01",336,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"195","NCT00834314",20,3,FALSE,"2010-02-01","2014-05-01",1551,"Intovalue","extended obligations of amended medical device law in Germany 2010 did not allow to continue and complete the trial due to budget limitation","non_scientific_reason","Lack of funding"
"196","NCT02675816",40,16,FALSE,"2015-08-01","2016-07-01",336,"Intovalue","Study halted due to low recruitment. Reimbursement changes require a larger study with additional centers and therefore, a new study planned as replacement.","non_scientific_reason","Low accrual rate"
"197","NCT02139098",150,23,FALSE,"2014-05-01","2017-11-01",1281,"Intovalue","Recruiting problems because of the time expenditure required for participating and the strict criteria of inclusion and exclusion","non_scientific_reason","Low accrual rate"
"198","NCT02207309",150,1,FALSE,"2015-06-22","2016-07-29",404,"Intovalue","poor recruitment","non_scientific_reason","Low accrual rate"
"199","NCT01690325",94,21,FALSE,"2012-09-01","2016-11-01",1523,"Intovalue","Therapy of HER2+ patients according to protocol was no longer appropriate. Patient enrolment behind planned schedule and challenges of site performance","scientific_reason","External evidence"
"200","NCT01439958",75,14,FALSE,"2012-02-01","2013-07-01",517,"Intovalue","Core study 12011.201 was terminated.","other","Other"
"201","NCT01419002",120,5,FALSE,"2011-10-01","2014-10-01",1097,"Intovalue","lack of recruitment","non_scientific_reason","Low accrual rate"
"202","NCT01407679",30,7,FALSE,"2011-08-01","2014-10-01",1158,"Intovalue","[No reason posted]","reason_not_provided","Reason not provided"
"203","NCT01303250",170,31,FALSE,"2011-04-01","2015-04-01",1462,"Intovalue","The final decision of the review of HES-containing solution shall be awaited.","scientific_reason","External evidence"
"204","NCT00413127",150,78,FALSE,"2007-09-01","2014-03-01",2374,"Intovalue","Less patients than expected for inclusion, therefore patient recruitment is to low","non_scientific_reason","Low accrual rate"
"205","NCT02058810",100,46,FALSE,"2010-09-01","2014-05-01",1339,"Intovalue","Lack of patients, PI left","non_scientific_reason","Low accrual rate"
"206","NCT02739685",144,17,FALSE,"2016-09-01","2018-05-01",608,"Intovalue","Slow enrollment, access to devices","non_scientific_reason","Low accrual rate"
"207","NCT02632292",224,33,FALSE,"2016-01-01","2018-04-01",822,"Intovalue","Slow enrollment","non_scientific_reason","Low accrual rate"
"208","NCT01312623",180,31,FALSE,"2010-03-01","2016-03-01",2193,"Intovalue","Terminated, because it is not possible to recruit enough participants","non_scientific_reason","Low accrual rate"
"209","NCT02140138",36,35,FALSE,"2014-06-01","2016-04-01",671,"Intovalue","Recruitment was terminated after enrolment of 35 instead of 36 evaluable patients for administrative reasons.","non_scientific_reason","Administrative, logistical, or technical issues"
"210","NCT01683864",60,3,TRUE,"2012-09-01","2015-05-01",973,"Intovalue","Recruitment problems","non_scientific_reason","Low accrual rate"
"211","NCT01582048",60,9,FALSE,"2012-04-01","2016-08-17",1600,"Intovalue","slow enrollment","non_scientific_reason","Low accrual rate"
"212","NCT01289938",42,49,FALSE,"2009-07-01","2015-06-01",2162,"Intovalue","To unsuccessful recruitment of rare UM-genotype. All other planned genotype groups are completed (EM, IM and PM).","non_scientific_reason","Low accrual rate"
"213","NCT00961142",60,23,FALSE,"2009-06-01","2015-12-30",2404,"Intovalue","slow recruitment","non_scientific_reason","Low accrual rate"
"214","NCT02198482",352,6,FALSE,"2016-02-01","2016-11-01",275,"Intovalue","development program of study drug volasertib was stopped by Boehringer Ingelheim due to manufacturing problems","non_scientific_reason","Lack of investigational product"
"215","NCT01837082",100,18,FALSE,"2013-04-01","2015-12-01",975,"Intovalue","Insufficient recruitment","non_scientific_reason","Low accrual rate"
"216","NCT01397149",82,4,FALSE,"2011-10-01","2013-11-01",763,"Intovalue","Insufficient recruitment","non_scientific_reason","Low accrual rate"
"217","NCT01611207",250,12,FALSE,"2012-06-01","2013-12-01",549,"Intovalue","The patient recruitment was behind target, no successful completion of the planned patient numbers within trial period could be expected","non_scientific_reason","Low accrual rate"
"218","NCT01165450",72,2,TRUE,"2011/11/01 00:00:00","2014-02-01",824,"Contrast","Drug manufacturer could not supply study drug.","non_scientific_reason","Lack of investigational product"
"219","NCT00506909",40,21,TRUE,"2008/03/01 00:00:00","2014-03-01",2192,"Contrast","Break in funding","non_scientific_reason","Lack of funding"
"220","NCT00470548",73,49,TRUE,"2007/04/01 00:00:00","2014-10-01",2741,"Contrast","Practice patterns with pemetrexed have evolved.","scientific_reason","External evidence"
"221","NCT01614067",114,30,TRUE,"2012/05/01 00:00:00","2014-07-01",792,"Contrast","Slow enrollment resulted in withdraw of funding","non_scientific_reason","Low accrual rate"
"222","NCT01061671",1126,885,TRUE,"2010/03/01 00:00:00","2014-01-01",1403,"Contrast","Futility","scientific_reason","Evidence of futility"
"223","NCT02566278",20,20,FALSE,"2015/10/20 00:00:00","2016-07-25",280,"Contrast","Data collection has been halted. We are not recruiting any more subjects.","other","Other"
"224","NCT01373918",120,41,TRUE,"2010/12/01 00:00:00","2014-07-01",1309,"Contrast","The study was terminated due to slow enrollment.","non_scientific_reason","Low accrual rate"
"225","NCT02120027",500,558,TRUE,"2014/02/01 00:00:00","2015-10-01",580,"Contrast","Because of negative results of the sister study NAK-06 and the low overall response rate at week 24.","scientific_reason","External evidence"
"226","NCT01963403",130,26,TRUE,"2013/12/01 00:00:00","2015-08-01",609,"Contrast","Futility of recruitment","non_scientific_reason","Low accrual rate"
"227","NCT01123161",400,120,TRUE,"2010/06/01 00:00:00","2015-04-01",1766,"Contrast","The ICTuS 2 portion of the trial has been halted and data will be analyzed.","other","Other"
"228","NCT01261299",80,21,FALSE,"2010/12/01 00:00:00","2017-06-01",2375,"Contrast","Contract ended","non_scientific_reason","Administrative, logistical, or technical issues"
"229","NCT02605304",40,7,TRUE,"2016/02/17 00:00:00","2017-01-20",339,"Contrast","The study experienced enrollment difficulties.","non_scientific_reason","Low accrual rate"
"230","NCT02215161",54,14,TRUE,"2014/09/02 00:00:00","2017-02-15",898,"Contrast","Risk to benefit ratio is not acceptable","scientific_reason","Evidence of harm"
"231","NCT02428309",18,1,TRUE,"2015/08/27 00:00:00","2016-09-02",373,"Contrast","Due to participant recruitment feasibility","non_scientific_reason","Low accrual rate"
"232","NCT01116661",50,199,TRUE,"2010/08/01 00:00:00","2017-12-28",2707,"Contrast","The primary objective for high grade gliomas has been met and the FDA has now approved the drug (Gleolan) for use in the United States.","scientific_reason","Evidence of benefit"
"233","NCT02147301",51,17,TRUE,"2014/12/17 00:00:00","2017-01-27",773,"Contrast","Risk to benefit ratio is not acceptable","scientific_reason","Evidence of harm"
"234","NCT02444793",70,24,TRUE,"2015/05/01 00:00:00","2017-09-26",855,"Contrast","The study was terminated due to marginal efficacy and change in sponsor prioritization. The combination had a manageable safety profile.","scientific_reason","Evidence of futility"
"235","NCT02465983",12,4,FALSE,"2015/05/01 00:00:00","2017-09-01",855,"Contrast","Lack of efficacy and funding to continue investigation","scientific_reason","Evidence of futility"
"236","NCT02205307",800,347,TRUE,"2015/01/01 00:00:00","2017-05-01",852,"Contrast","Slow recruitment","non_scientific_reason","Low accrual rate"
"237","NCT02254902",100,27,FALSE,"2014/09/01 00:00:00","2015-12-01",457,"Contrast","Changes in funding status","non_scientific_reason","Lack of funding"
"238","NCT01601626",426,71,TRUE,"2013/07/13 00:00:00","2017-01-19",1287,"Contrast","The study was stopped early due to feasibility concerns.","non_scientific_reason","Administrative, logistical, or technical issues"
"239","NCT01098422",34,10,TRUE,"2010/01/01 00:00:00","2015-01-01",1827,"Contrast","Halted due to slow enrollment","non_scientific_reason","Low accrual rate"
"240","NCT02093962",440,265,TRUE,"2014/06/01 00:00:00","2016-04-01",671,"Contrast","At the interim analysis, the futility boundary was not met and the study was stopped due to insufficient efficacy.","scientific_reason","Evidence of futility"
"241","NCT02508441",76,22,FALSE,"2015/12/08 00:00:00","2017-11-13",707,"Contrast","Part 1 of the study was completed and the maximum tolerated dose determined. Part 2 of the study was terminated and will be conducted under a new protocol.","other","Other"
"242","NCT01562132",100,6,TRUE,"2013/09/01 00:00:00","2014-07-01",304,"Contrast","Stopped in accordance with pre-specified stopping rules for poor recruitment.","non_scientific_reason","Low accrual rate"
"243","NCT01841307",15,16,FALSE,"2015/07/01 00:00:00","2017-03-01",610,"Contrast","Difficulty recruiting; Funding ended; interim analysis provided sufficient data for interpretation.","non_scientific_reason","Low accrual rate"
"244","NCT01313923",15,3,TRUE,"2011/02/01 00:00:00","2014-10-01",1339,"Contrast","Lack of funding","non_scientific_reason","Lack of funding"
"245","NCT01510756",10,4,TRUE,"2011/12/01 00:00:00","2014-05-01",883,"Contrast","slow enrollment","non_scientific_reason","Low accrual rate"
"246","NCT01838499",100,224,TRUE,"2013/05/01 00:00:00","2014-10-01",519,"Contrast","At the planned IA for decision making, no evidence was demonstrated of MEDI8968 activity in reducing (HS) severity or pain over that seen with placebo.","scientific_reason","Evidence of futility"
"247","NCT01391949",70,7,FALSE,"2011/07/01 00:00:00","2015-06-01",1432,"Contrast","[No reason posted]","reason_not_provided","Reason not provided"
"248","NCT02046928",20,5,FALSE,"2014/02/01 00:00:00","2015-11-01",639,"Contrast","Slow enrollment","non_scientific_reason","Low accrual rate"
"249","NCT02327637",130,5,FALSE,"2014/12/01 00:00:00","2016-12-12",743,"Contrast","Low recruitment","non_scientific_reason","Low accrual rate"
"250","NCT00771862",30,16,FALSE,"2008/10/01 00:00:00","2017-05-30",3164,"Contrast","Could not secure funding to complete the study.","non_scientific_reason","Lack of funding"
"251","NCT02644122",29,1,TRUE,"2016/11/01 00:00:00","2017-06-01",213,"Contrast","Slow enrollment","non_scientific_reason","Low accrual rate"
"252","NCT02177773",120,300,TRUE,"2014/06/23 00:00:00","2017-08-07",1142,"Contrast","FDA approved agent for this indication during enrollment","scientific_reason","External evidence"
"253","NCT02078895",80,15,FALSE,"2014/02/01 00:00:00","2017-02-01",1097,"Contrast","The study was terminated due to low enrollment","non_scientific_reason","Low accrual rate"
"254","NCT02591381",400,3,FALSE,"2015/10/01 00:00:00","2017-10-01",732,"Contrast","Study was started but closed prior to completion because we could not meet enrollment numbers","non_scientific_reason","Low accrual rate"
"255","NCT02719730",60,5,FALSE,"2016/06/22 00:00:00","2016-08-02",42,"Contrast","Change in study design to be a pilot with no randomization to intervention&#x2F;control","non_scientific_reason","Administrative, logistical, or technical issues"
"256","NCT02317276",15,11,TRUE,"2014/12/01 00:00:00","2017-04-06",858,"Contrast","Unable to meet the study&#x27;s recruitment goals","non_scientific_reason","Low accrual rate"
"257","NCT02634606",NA,13,TRUE,"2011/03/22 00:00:00","2017-10-01",671,"Contrast","Unable to obtain supplement for this study. Unable to recruit.","non_scientific_reason","Lack of investigational product"
"258","NCT02745353",60,7,TRUE,"2016/05/01 00:00:00","2017-06-22",418,"Contrast","Couldn&#x27;t enough accrue patients","non_scientific_reason","Low accrual rate"
"259","NCT02368691",55,32,TRUE,"2015/06/01 00:00:00","2017-09-22",845,"Contrast","Lack of Efficacy","scientific_reason","Evidence of futility"
"260","NCT01390584",200,6,TRUE,"2012/04/02 00:00:00","2014-01-01",641,"Contrast","slow accrual","non_scientific_reason","Low accrual rate"
"261","NCT01683747",200,4,FALSE,"2012/06/01 00:00:00","2014-11-01",884,"Contrast","Lower than anticipated enrollment","non_scientific_reason","Low accrual rate"
"262","NCT01829347",100,18,TRUE,"2014/04/01 00:00:00","2015-10-01",549,"Contrast","Due to results from the VTI-208 study, the ELAD plan is being re-evaluated.","scientific_reason","External evidence"
"263","NCT02354092",108,14,TRUE,"2015/04/02 00:00:00","2015-08-25",146,"Contrast","[No reason posted]","reason_not_provided","Reason not provided"
"264","NCT02605824",20,1,TRUE,"2016/03/01 00:00:00","2017-12-01",641,"Contrast","The study was closed after we determined that this albuterol&#x2F;NAC regimen may be associated with excessive bronchoconstriction.","scientific_reason","Evidence of harm"
"265","NCT01545648",45,4,TRUE,"2012/11/01 00:00:00","2015-06-09",951,"Contrast","Low Accrual","non_scientific_reason","Low accrual rate"
"266","NCT00632827",45,21,TRUE,"2008/07/01 00:00:00","2014-06-23",2184,"Contrast","Manufacturing shortage of both Diftitox and Doxil","non_scientific_reason","Lack of investigational product"
"267","NCT01641601",80,8,TRUE,"2012/07/01 00:00:00","2015-07-01",1096,"Contrast","Inadequate enrollment. Key study personnel transitioned to a different role.","non_scientific_reason","Low accrual rate"
"268","NCT02567448",100,24,FALSE,"2015/07/01 00:00:00","2016-08-11",408,"Contrast","Failed to accrue","non_scientific_reason","Low accrual rate"
"269","NCT01821443",45,10,FALSE,"2012/12/01 00:00:00","2015-10-22",1056,"Contrast","Loss of funding","non_scientific_reason","Lack of funding"
"270","NCT01709474",78,7,TRUE,"2013/06/01 00:00:00","2014-07-01",396,"Contrast","Due to slow enrollment","non_scientific_reason","Low accrual rate"
"271","NCT02307552",10,1,TRUE,"2013/06/01 00:00:00","2014-04-01",305,"Contrast","The probe could not be anchored in place and would rotate about its axis, thus comparison was difficult.","non_scientific_reason","Lack of investigational product"
"272","NCT01721603",39,2,TRUE,"2013/04/01 00:00:00","2016-01-01",1006,"Contrast","Low accrual","non_scientific_reason","Low accrual rate"
"273","NCT01780636",30,7,TRUE,"2013/01/01 00:00:00","2014-01-01",366,"Contrast","POOR RECRUITMENT","non_scientific_reason","Low accrual rate"
"274","NCT02294981",30,4,TRUE,"2016/01/01 00:00:00","2017-09-01",610,"Contrast","Protocol was changed to make it easier for treating doctors. No safety concerns","non_scientific_reason","Administrative, logistical, or technical issues"
"275","NCT02524106",200,11,TRUE,"2016/08/01 00:00:00","2019-04-01",974,"Contrast","Industry won&#x27;t be moving forward with production of bococizumab","non_scientific_reason","Lack of investigational product"
"276","NCT01211756",20,1,TRUE,"2010/10/01 00:00:00","2015-02-01",1585,"Contrast","Break in funding","non_scientific_reason","Lack of funding"
"277","NCT02672033",10,2,TRUE,"2015/09/01 00:00:00","2018-07-17",1051,"Contrast","slow enrollment","non_scientific_reason","Low accrual rate"
"278","NCT01046773",20,3,FALSE,"2010/01/01 00:00:00","2017-05-01",2678,"Contrast","Low enrollment","non_scientific_reason","Low accrual rate"
"279","NCT01773746",1260,80,FALSE,"2013/08/01 00:00:00","2017-03-01",1309,"Contrast","Poor Recruitment","non_scientific_reason","Low accrual rate"
"280","NCT01617291",400,46,FALSE,"2013/03/01 00:00:00","2014-02-01",338,"Contrast","A similar study was recently published with definitive results.","scientific_reason","External evidence"
"281","NCT01737593",246,108,TRUE,"2012/11/01 00:00:00","2014-04-01",517,"Contrast","Interim analysis revealed a negative effect.","scientific_reason","Evidence of harm"
"282","NCT01943188",14,2,FALSE,"2014/05/01 00:00:00","2016-03-01",671,"Contrast","[No reason posted]","reason_not_provided","Reason not provided"
"283","NCT02381392",260,23,TRUE,"2014/08/01 00:00:00","2016-11-19",842,"Contrast","Insufficient enrollment, investigator left institution","non_scientific_reason","Low accrual rate"
"284","NCT01290523",30,14,TRUE,"2010/05/01 00:00:00","2014-05-01",1462,"Contrast","Off study clinical use of Y90 glass microspheres (TheraSphere)","scientific_reason","External evidence"
"285","NCT01778855",120,6,TRUE,"2013/02/01 00:00:00","2015-08-01",912,"Contrast","[No reason posted]","reason_not_provided","Reason not provided"
"286","NCT01502761",20,4,TRUE,"2012/03/01 00:00:00","2016-05-01",1523,"Contrast","No safety issues. Low enrollment secondary to negative stroke studies 2013","scientific_reason","External evidence"
"287","NCT00610467",120,2,TRUE,"2006/10/01 00:00:00","2016-10-01",3654,"Contrast","Slow accrual","non_scientific_reason","Low accrual rate"
"288","NCT02170298",40,6,TRUE,"2014/02/01 00:00:00","2015-06-01",486,"Contrast","Lack of enrollment","non_scientific_reason","Low accrual rate"
"289","NCT01402544",40,20,TRUE,"2011/07/01 00:00:00","2015-03-01",1340,"Contrast","Per study sponsor decision.","non_scientific_reason","Administrative, logistical, or technical issues"
"290","NCT00751101",80,24,TRUE,"2007/08/20 00:00:00","2014-03-24",2409,"Contrast","Low Accrual","non_scientific_reason","Low accrual rate"
"291","NCT02728700",9,1,FALSE,"2016/02/01 00:00:00","2018-07-01",882,"Contrast","Accrual factor","non_scientific_reason","Low accrual rate"
"292","NCT01615042",18,6,FALSE,"2012/08/01 00:00:00","2017-05-01",1735,"Contrast","Lack of enrollment","non_scientific_reason","Low accrual rate"
"293","NCT01138553",66,4,FALSE,"2010/06/01 00:00:00","2014-06-01",1462,"Contrast","Inadequate subject accrual","non_scientific_reason","Low accrual rate"
"294","NCT02280395",150,9,FALSE,"2014/10/01 00:00:00","2015-06-01",244,"Contrast","Company merger resulted in business decision to terminate the study.","non_scientific_reason","Administrative, logistical, or technical issues"
"295","NCT01826305",120,23,FALSE,"2014/07/01 00:00:00","2015-10-23",480,"Contrast","[No reason posted]","reason_not_provided","Reason not provided"
"296","NCT02450201",10,5,FALSE,"2016/10/12 00:00:00","2017-01-17",98,"Contrast","Low accrual","non_scientific_reason","Low accrual rate"
"297","NCT01695473",24,11,TRUE,"2013/04/23 00:00:00","2015-02-05",654,"Contrast","Lack of Accrual","non_scientific_reason","Low accrual rate"
"298","NCT01442714",50,33,TRUE,"2011/08/01 00:00:00","2014-08-01",1097,"Contrast","Lack of efficacy - Inability to meet the primary response endpoint","scientific_reason","Evidence of futility"
"299","NCT01055028",20,18,TRUE,"2010/02/01 00:00:00","2016-03-01",2221,"Contrast","Poor accrual","non_scientific_reason","Low accrual rate"
"300","NCT02206776",50,2,TRUE,"2014/09/01 00:00:00","2015-05-01",243,"Contrast","poor tolerability and low enrollment rate","scientific_reason","Evidence of harm"
"301","NCT01719861",10,6,TRUE,"2012/10/01 00:00:00","2014-05-01",578,"Contrast","Lack of efficacy","scientific_reason","Evidence of futility"
"302","NCT01965002",30,5,TRUE,"2014/05/01 00:00:00","2015-03-24",328,"Contrast","Accrual factor","non_scientific_reason","Low accrual rate"
"303","NCT02855086",10,3,TRUE,"2016/10/01 00:00:00","2016-11-08",39,"Contrast","logistics","non_scientific_reason","Administrative, logistical, or technical issues"
"304","NCT02736578",10,8,TRUE,"2016/07/01 00:00:00","2017-04-24",298,"Contrast","Logistics","non_scientific_reason","Administrative, logistical, or technical issues"
"305","NCT02757547",10,2,TRUE,"2015/09/01 00:00:00","2017-11-15",807,"Contrast","Business decision to discontinue development of this investigational device.","non_scientific_reason","Administrative, logistical, or technical issues"
"306","NCT01034514",30,35,FALSE,"2009/12/01 00:00:00","2014-06-24",1667,"Contrast","business decision","non_scientific_reason","Administrative, logistical, or technical issues"
"307","NCT01094587",54,39,FALSE,"2009/11/01 00:00:00","2015-06-24",2062,"Contrast","Enrollment difficulty","non_scientific_reason","Low accrual rate"
"308","NCT01123005",40,28,FALSE,"2010/12/01 00:00:00","2015-08-21",1725,"Contrast","Logistical","non_scientific_reason","Administrative, logistical, or technical issues"
"309","NCT01987375",12,1,FALSE,"2015/11/01 00:00:00","2017-04-19",536,"Contrast","logistics","non_scientific_reason","Administrative, logistical, or technical issues"
"310","NCT01067144",560,422,TRUE,"2010/05/01 00:00:00","2016-07-01",2254,"Contrast","Trial met futility stopping point","scientific_reason","Evidence of futility"
"311","NCT02586415",476,182,TRUE,"2016/04/01 00:00:00","2017-08-01",488,"Contrast","Interim analysis showed a high likelihood of benefit in the endovascular group","scientific_reason","Evidence of benefit"
"312","NCT02303041",40,10,TRUE,"2015/02/01 00:00:00","2017-04-01",791,"Contrast","Business Decision","non_scientific_reason","Administrative, logistical, or technical issues"
"313","NCT01020812",24,11,TRUE,"2009/09/01 00:00:00","2014-03-01",1643,"Contrast","enrollment was too low","non_scientific_reason","Low accrual rate"
"314","NCT01506726",60,11,TRUE,"2012/03/01 00:00:00","2014-10-01",945,"Contrast","Study drug expiration and supply shortage","non_scientific_reason","Lack of investigational product"
"315","NCT01868503",22,7,TRUE,"2013/07/01 00:00:00","2014-12-01",519,"Contrast","Protocol modification","other","Other"
"316","NCT01406795",15,1,TRUE,"2010/12/01 00:00:00","2014-12-01",1462,"Contrast","Poor enrollment and advances in venoplasty only techniques of the femoral vein","scientific_reason","External evidence"
"317","NCT01313884",20,3,TRUE,"2011/05/01 00:00:00","2013-11-01",916,"Contrast","Study did not reach primary objective; study did not accrue enough patients.","non_scientific_reason","Low accrual rate"
"318","NCT01893879",120,14,TRUE,"2014/04/01 00:00:00","2015-04-01",366,"Contrast","insufficient enrollment","non_scientific_reason","Low accrual rate"
"319","NCT01928030",23,3,TRUE,"2013/12/01 00:00:00","2015-11-01",701,"Contrast","Low accrual","non_scientific_reason","Low accrual rate"
"320","NCT01364259",208,17,TRUE,"2008/09/01 00:00:00","2014-01-01",1949,"Contrast","Patterns of practice changed and this technique is no longer used.","scientific_reason","External evidence"
"321","NCT01769222",69,3,TRUE,"2013/02/01 00:00:00","2014-11-01",639,"Contrast","Planned Future Study","other","Other"
"322","NCT03023709",NA,3,TRUE,"2015/09/01 00:00:00","2015-12-01",92,"Contrast","Due to the ACIP guidelines halting the use of LAIV","scientific_reason","External evidence"
"323","NCT01823679",19,2,TRUE,"2013/03/01 00:00:00","2014-05-01",427,"Contrast","Low accrual","non_scientific_reason","Low accrual rate"
"324","NCT02030405",16,4,TRUE,"2014/03/01 00:00:00","2015-11-01",611,"Contrast","Regulatory","scientific_reason","Evidence of harm"
"325","NCT02175745",50,2,TRUE,"2014/12/01 00:00:00","2015-08-01",244,"Contrast","Re-evaluate indication with the referring physicians","other","Other"
"326","NCT03028987",NA,10,TRUE,"2014/11/19 00:00:00","2015-11-18",365,"Contrast","LAIV was no longer recommended by ACIP","scientific_reason","External evidence"
"327","NCT00481832",25,50,TRUE,"2007/01/01 00:00:00","2014-10-27",2857,"Contrast","Accrual Factor","non_scientific_reason","Low accrual rate"
"328","NCT02877732",100,12,TRUE,"2016/07/01 00:00:00","2017-04-01",275,"Contrast","The funding sponsor elected to terminate the study.","non_scientific_reason","Lack of funding"
"329","NCT02415608",11,4,TRUE,"2015/03/01 00:00:00","2017-03-14",745,"Contrast","Slow accrual","non_scientific_reason","Low accrual rate"
"330","NCT01846624",36,13,TRUE,"2013/06/01 00:00:00","2016-07-22",1148,"Contrast","Accrual factor","non_scientific_reason","Low accrual rate"
"331","NCT03206216",50,1,TRUE,"2017/08/04 00:00:00","2017-10-30",88,"Contrast","Business decision","non_scientific_reason","Administrative, logistical, or technical issues"
"332","NCT01472445",60,41,TRUE,"2011/11/01 00:00:00","2014-10-01",1066,"Contrast","Slow accrual","non_scientific_reason","Low accrual rate"
"333","NCT00568633",150,58,TRUE,"2007/08/01 00:00:00","2017-12-01",3776,"Contrast","Poor accrual","non_scientific_reason","Low accrual rate"
"334","NCT03061279",500,1,TRUE,"2017/04/01 00:00:00","2017-10-26",209,"Contrast","Problem negotiating other sites","non_scientific_reason","Administrative, logistical, or technical issues"
"335","NCT01745354",12,6,FALSE,"2012/08/01 00:00:00","2014-11-01",823,"Contrast","Accrual issues - Slow accrual","non_scientific_reason","Low accrual rate"
"336","NCT01857752",16,3,FALSE,"2012/03/01 00:00:00","2015-06-01",1188,"Contrast","accrual","non_scientific_reason","Low accrual rate"
"337","NCT01904643",30,17,FALSE,"2014/02/01 00:00:00","2015-05-13",467,"Contrast","Accrual factor","non_scientific_reason","Low accrual rate"
"338","NCT02075190",150,89,FALSE,"2014/02/01 00:00:00","2015-08-01",547,"Contrast","Dr. Gyurak is no longer doing and ended her NARSAD early.","non_scientific_reason","Principal investigator departure"
"339","NCT02436460",12,4,FALSE,"2015/05/01 00:00:00","2016-03-01",306,"Contrast","Re-initiate a new trial per the discussion with FDA","scientific_reason","Internal evidence (unspecified)"
"340","NCT02042157",400,28,FALSE,"2015/01/01 00:00:00","2016-12-01",701,"Contrast","Equipment malfunction.","non_scientific_reason","Administrative, logistical, or technical issues"
"341","NCT02890875",40,3,FALSE,"2016/08/01 00:00:00","2018-09-01",762,"Contrast","Low recruitment","non_scientific_reason","Low accrual rate"
"342","NCT01188486",12,12,FALSE,"2010/08/01 00:00:00","2017-04-30",2465,"Contrast","Business decision","non_scientific_reason","Administrative, logistical, or technical issues"
"343","NCT02429804",15,4,FALSE,"2015/04/01 00:00:00","2017-05-15",776,"Contrast","Accrual factor","non_scientific_reason","Low accrual rate"
"344","NCT02435225",50,14,FALSE,"2014/05/01 00:00:00","2014-06-01",32,"Contrast","Change in goals of PI","non_scientific_reason","Administrative, logistical, or technical issues"
"345","NCT02708511",10,2,FALSE,"2016/08/01 00:00:00","2017-10-11",437,"Contrast","[No reason posted]","reason_not_provided","Reason not provided"
"346","NCT02049801",19,1,FALSE,"2014/12/01 00:00:00","2015-02-04",66,"Contrast","logistics","non_scientific_reason","Administrative, logistical, or technical issues"
"347","NCT02635074",18,2,FALSE,"2016/11/01 00:00:00","2017-07-18",260,"Contrast","safety","scientific_reason","Evidence of harm"
"348","NCT01192776",726,364,TRUE,"2010/09/01 00:00:00","2016-03-01",2009,"Contrast","The trial closed for emerging safety profile and futility analysis and will not resume.","scientific_reason","Evidence of harm"
"349","NCT01954082",1760,638,TRUE,"2014/04/17 00:00:00","2016-06-01",793,"Contrast","Study terminated due to safety concerns; participant follow up will continue until March 2018","scientific_reason","Evidence of harm"
"350","NCT01614652",478,331,FALSE,"2012/12/01 00:00:00","2017-06-01",1644,"Contrast","Company is closed","non_scientific_reason","Administrative, logistical, or technical issues"
"351","NCT02057991",300,94,FALSE,"2014/01/07 00:00:00","2017-01-01",1097,"Contrast","Insufficient Accrual","non_scientific_reason","Low accrual rate"
"352","NCT03115385",NA,22,FALSE,"2015/05/30 00:00:00","2016-04-11",318,"Contrast","Funds ended.","non_scientific_reason","Lack of funding"
"353","NCT01302405",64,23,FALSE,"2011/02/01 00:00:00","2015-01-01",1431,"Contrast","closing due to low enrollment, no safety issues","non_scientific_reason","Low accrual rate"
"354","NCT01153919",36,27,FALSE,"2010/06/30 00:00:00","2014-07-14",1476,"Contrast","Approval of several new agents for the treatment of HCV infection would mitigate the future need for interferon HCV treatment","scientific_reason","External evidence"
"355","NCT01801046",35,10,FALSE,"2013/03/06 00:00:00","2017-07-27",1605,"Contrast","Insufficient Accrual","non_scientific_reason","Low accrual rate"
"356","NCT01238965",50,7,FALSE,"2010/10/01 00:00:00","2015-06-01",1705,"Contrast","Adverse Events","scientific_reason","Evidence of harm"
"357","NCT00556907",116,22,FALSE,"2007/10/01 00:00:00","2013-12-01",2254,"Contrast","Lack of Funding","non_scientific_reason","Lack of funding"
"358","NCT01469338",50,9,FALSE,"2012/07/01 00:00:00","2014-10-01",823,"Contrast","lack of funding","non_scientific_reason","Lack of funding"
"359","NCT02967380",NA,14,FALSE,"2011/12/14 00:00:00","2014-05-01",883,"Contrast","Insufficient Accrual","non_scientific_reason","Low accrual rate"
"360","NCT02270684",50,4,TRUE,"2015/05/01 00:00:00","2016-01-01",246,"Contrast","Recruitment and retention difficulties","non_scientific_reason","Low accrual rate"
"361","NCT01866423",50,4,TRUE,"2013/10/25 00:00:00","2015-10-01",731,"Contrast","Not progressing toward scientific goals","scientific_reason","Evidence of futility"
"362","NCT01518465",30,13,FALSE,"2012/01/09 00:00:00","2016-12-31",1819,"Contrast","Insufficient Accrual","non_scientific_reason","Low accrual rate"
"363","NCT02370264",150,36,FALSE,"2012/10/01 00:00:00","2015-09-02",1067,"Contrast","Study not progressing toward scientific goals","scientific_reason","Evidence of futility"
"364","NCT02127892",15,9,TRUE,"2007/01/02 00:00:00","2016-08-01",3500,"Contrast","Closed due to slow accrual. Nine subjects enrolled over 7 years.","non_scientific_reason","Low accrual rate"
"365","NCT03104816",128,28,TRUE,"2016/10/01 00:00:00","2017-10-01",366,"Contrast","Could not get an approval from Department Reviewer for the study continuation.","non_scientific_reason","Administrative, logistical, or technical issues"
"366","NCT01649258",39,29,FALSE,"2012/09/04 00:00:00","2017-09-04",1827,"Contrast","Lack of Efficacy","scientific_reason","Evidence of futility"
"367","NCT02067884",50,34,FALSE,"2013/12/19 00:00:00","2016-09-25",1012,"Contrast","Slow accrual","non_scientific_reason","Low accrual rate"
